78 related articles for article (PubMed ID: 11436087)
1. Use of cryopreserved cadaveric vein allograft for hemodialysis access precludes kidney transplantation because of allosensitization.
Benedetto B; Lipkowitz G; Madden R; Kurbanov A; Hull D; Miller M; Bow L
J Vasc Surg; 2001 Jul; 34(1):139-42. PubMed ID: 11436087
[TBL] [Abstract][Full Text] [Related]
2. Decellularized cadaver vein allografts used for hemodialysis access do not cause allosensitization or preclude kidney transplantation.
Madden R; Lipkowitz G; Benedetto B; Kurbanov A; Miller M; Bow L
Am J Kidney Dis; 2002 Dec; 40(6):1240-3. PubMed ID: 12460043
[TBL] [Abstract][Full Text] [Related]
3. Sensitization of renal transplant candidates by cryopreserved cadaveric venous or arterial allografts.
Lopez-Cepero M; Sanders CE; Buggs J; Bowers V
Transplantation; 2002 Mar; 73(5):817-9. PubMed ID: 11907435
[TBL] [Abstract][Full Text] [Related]
4. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
5. Panel-reactive antibodies late after allograft implantation in children.
Hooper DK; Hawkins JA; Fuller TC; Profaizer T; Shaddy RE
Ann Thorac Surg; 2005 Feb; 79(2):641-4; discussion 645. PubMed ID: 15680851
[TBL] [Abstract][Full Text] [Related]
6. Allosensitization of islet allograft recipients.
Cardani R; Pileggi A; Ricordi C; Gomez C; Baidal DA; Ponte GG; Mineo D; Faradji RN; Froud T; Ciancio G; Esquenazi V; Burke GW; Selvaggi G; Miller J; Kenyon NS; Alejandro R
Transplantation; 2007 Dec; 84(11):1413-27. PubMed ID: 18091517
[TBL] [Abstract][Full Text] [Related]
7. Creating arteriovenous fistulas in 132 consecutive patients: exploiting the proximal radial artery arteriovenous fistula: reliable, safe, and simple forearm and upper arm hemodialysis access.
Jennings WC
Arch Surg; 2006 Jan; 141(1):27-32; discussion 32. PubMed ID: 16415408
[TBL] [Abstract][Full Text] [Related]
8. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
Barocci S; Valente U; Nocera A
Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
[TBL] [Abstract][Full Text] [Related]
9. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
[TBL] [Abstract][Full Text] [Related]
10. Clinical application and viability of cryopreserved cadaveric skin allografts in severe burn: a retrospective analysis.
Cleland H; Wasiak J; Dobson H; Paul M; Pratt G; Paul E; Herson M; Akbarzadeh S
Burns; 2014 Feb; 40(1):61-6. PubMed ID: 24018216
[TBL] [Abstract][Full Text] [Related]
11. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
12. Use of an allograft patch in repair of hypoplastic left heart syndrome may complicate future transplantation.
Meyer SR; Campbell PM; Rutledge JM; Halpin AM; Hawkins LE; Lakey JR; Rebeyka IM; Ross DB
Eur J Cardiothorac Surg; 2005 Apr; 27(4):554-60. PubMed ID: 15784350
[TBL] [Abstract][Full Text] [Related]
13. Alloantibodies and the outcome of cadaver kidney allografts.
Vasilescu ER; Ho EK; Colovai AI; Vlad G; Foca-Rodi A; Markowitz GS; D'Agati V; Hardy MA; Ratner LE; Suciu-Foca N
Hum Immunol; 2006 Aug; 67(8):597-604. PubMed ID: 16916655
[TBL] [Abstract][Full Text] [Related]
14. Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry.
Takemoto S; Terasaki PI; Cecka JM; Cho YW; Gjertson DW
N Engl J Med; 1992 Sep; 327(12):834-9. PubMed ID: 1508242
[TBL] [Abstract][Full Text] [Related]
15. Causes of sensitisation in patients awaiting renal transplantation in Ireland.
Soosay A; O'Neill D; Counihan A; Hickey D; Keogan M
Ir Med J; 2003 Apr; 96(4):109-12. PubMed ID: 12793472
[TBL] [Abstract][Full Text] [Related]
16. Impact of positive PRA on the results of ABO-incompatible kidney transplantation.
Shimmura H; Tanabe K; Tokumoto T; Ishida H; Ishikawa N; Miyamoto N; Shimizu T; Shirakawa H; Setoguchi K; Toma H
Transplant Proc; 2004 Sep; 36(7):2169-71. PubMed ID: 15518789
[TBL] [Abstract][Full Text] [Related]
17. Effect of panel-reactive antibody in predicting crossmatch selection of cadaveric kidney recipients.
Lieber SR; Perez FV; Tabossi MR; Persoli LB; Marques SB; Mazzali M; Alves-Filho G; de Souza CA
Transplant Proc; 2007 Mar; 39(2):429-31. PubMed ID: 17362748
[TBL] [Abstract][Full Text] [Related]
18. Suggested treatment protocol for improving patency of femoral-infrapopliteal cryopreserved saphenous vein allografts.
Buckley CJ; Abernathy S; Lee SD; Arko FR; Patterson DE; Manning LG
J Vasc Surg; 2000 Oct; 32(4):731-8. PubMed ID: 11013037
[TBL] [Abstract][Full Text] [Related]
19. Efficiency of the kidney disease outcomes quality initiative guidelines for preemptive vascular access in an academic setting.
Kimball TA; Barz K; Dimond KR; Edwards JM; Nehler MR
J Vasc Surg; 2011 Sep; 54(3):760-5; discussion 765-6. PubMed ID: 21703804
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C, acute humoral rejection, and renal allograft survival.
Forman JP; Tolkoff-Rubin N; Pascual M; Lin J
J Am Soc Nephrol; 2004 Dec; 15(12):3249-55. PubMed ID: 15579529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
